Frequency Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.90 | $1.25 | $1.58 |
| Q2 2024 | 0 | $1.62 | $1.06 | $1.34 |
| Q3 2024 | 0 | $1.86 | $1.22 | $1.54 |
Frequency Therapeutics, Inc. Earnings Date And Information
Frequency Therapeutics, Inc. last posted its earnings results on Tuesday, November 14th, 2023. The company reported $-0.55 earnings per share for the quarter, topping analysts' consensus estimates of $-17.73 by $17.18. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Frequency Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-2.33 diluted earnings per share) and currently has a price-to-earnings ratio of -0.49. Frequency Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 1st, 2023 based on prior year's report dates.
Frequency Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/02/2023 | Q3 2023 | -$0.31 | $0 | $0 | ||
| 08/10/2023 | Q2 2023 | -$0.44 | -$0.30 | 0.14 | $0 | |
| 05/12/2023 | Q1 2023 | -$0.39 | -$0.55 | -0.16 | $0 | |
| 03/10/2023 | Q4 2022 | -$0.65 | -$0.49 | 0.16 | $0 | |
| 11/08/2022 | Q3 2022 | -$0.61 | -$0.55 | 0.06 | $15.19 M | $0 |
| 08/09/2022 | Q2 2022 | -$0.69 | -$0.61 | 0.08 | $6.27 M | $0 |
| 05/04/2022 | Q1 2022 | -$0.66 | -$0.67 | -0.01 | $0 | |
| 03/15/2022 | Q4 2021 | $0.37 | -$0.62 | -0.99 | $0 | |
| 11/15/2021 | Q3 2021 | -$0.55 | -$0.73 | -0.18 | $16.25 M | $0 |
| 08/12/2021 | Q2 2021 | -$0.51 | -$0.52 | -0.01 | $6.71 M | $9.42 M |
| 05/13/2021 | Q1 2021 | -$0.27 | -$0.60 | -0.33 | $4.65 M | |
| 03/29/2021 | Q4 2020 | -$0.30 | $9.95 M | |||
| 11/16/2020 | Q3 2020 | -$0.32 | -$0.16 | 0.16 | $14.46 M | $11.25 M |
| 08/12/2020 | Q2 2020 | -$0.22 | -$0.19 | 0.03 | $8.07 M | $8.52 M |
| 05/14/2020 | Q1 2020 | -$0.25 | -$0.16 | 0.09 | $7.26 M | |
| 03/26/2020 | Q4 2019 | -$0.18 | $4.71 M | |||
| 11/18/2019 | Q3 2019 | -$0.68 | -$0.02 | 0.66 | $22.46 M | $24.24 M |
| 06/29/2019 | Q2 2019 | -$0.22 | $0 | |||
| 03/30/2019 | Q1 2019 | -$0.48 | $0 | |||
| 12/30/2018 | Q4 2018 | -$0.45 | $0 |
Frequency Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Frequency Therapeutics, Inc.'s earnings date?
Frequency Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 1st, 2023 based off last year's report dates.
-
Did Frequency Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Frequency Therapeutics, Inc. (:FREQ) reported $-0.55 earnings per share (EPS) to beat the analysts' consensus estimate of $-17.73 by $17.18.
-
How can I listen to Frequency Therapeutics, Inc.'s earnings conference call?
The conference call for Frequency Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Frequency Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Frequency Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Frequency Therapeutics, Inc. generate each year?
Frequency Therapeutics, Inc. (:FREQ) has a recorded net income of $0. Frequency Therapeutics, Inc. has generated $-2.33 earnings per share over the last four quarters.
-
What is Frequency Therapeutics, Inc.'s price-to-earnings ratio?
Frequency Therapeutics, Inc. (:FREQ) has a price-to-earnings ratio of -0.49 and price/earnings-to-growth ratio is -0.04.
